Latest Market Share on Neuron Biopharma SA Product Pipeline Review 2014

1
Neuron Biopharma SA - Product Pipeline
Review 2014 www.bigmarketresearch.com
2
Acquired (Autoimmune) Hemolytic Anemia
Report Description
Summary Global Markets Directs, Neuron
Biopharma SA - Product Pipeline Review - 2014,
provides an overview of the Neuron Biopharma SAs
pharmaceutical research and development
focus. This report provides comprehensive
information on the current therapeutic
developmental pipeline of Neuron Biopharma SAs,
complete with comparative analysis at various
stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of
administration (RoA) and molecule type. It also
reviews latest updates, and featured news and
press releases, along with special features on
late-stage and discontinued projects. Get More
Details At http//www.bigmarketresearch.com/neuro
n-biopharma-sa-product-pipeline-review-2014-market

3
Report Description
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team.
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease.
4
Report Description

• Scope
• - The report provides brief overview of Neuron
  Biopharma SA including business description, key
  information and facts, and its locations and
  subsidiaries
• - The report reviews current pipeline of Neuron
  Biopharma SAs human therapeutic division and
  enlists all their major and minor projects
• - The report features product description and
  descriptive mechanism of action for key pipeline
  products along with the products developmental
  history and major milestones
• - Special feature on out-licensed and partnered
  product portfolio
• - The report summarizes all the dormant and
  discontinued pipeline projects
• - Latest company statement
• Latest news and deals relating to the Neuron
  Biopharma SAs pipeline products
• Enquire about report - http//www.bigmarketresearc
  h.com/report-enquiry/152199

5
Report Description

• Reasons to buy
• Evaluate Neuron Biopharma SAs strategic position
  with total access to detailed information on its
  product pipeline
• Assess the growth potential of Neuron Biopharma
  SA in its therapy areas of focus
• Identify new drug targets and therapeutic classes
  in the Neuron Biopharma SAs RD portfolio and
  develop key strategic initiatives to reinforce
  pipeline in those areas
• Exploit in-licensing opportunities by identifying
  windows of opportunity to fill portfolio gaps
• Develop strategic initiatives by understanding
  the focus areas of Neuron Biopharma SA and
  exploit collaboration and partnership
  opportunities

6
Report Description

• Reasons to buy
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of Neuron
  Biopharma SA
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and scope
• Explore the dormant and discontinued projects of
  Neuron Biopharma SA and identify potential
  opportunities in those areas
• Avoid Intellectual Property Rights related issues

7
Table Of Content
List of Tables List of Figures Neuron Biopharma
SA Snapshot Neuron Biopharma SA Overview Key
Information Key Facts Neuron Biopharma SA -
Research and Development Overview Key
Therapeutic Areas Neuron Biopharma SA - Pipeline
Review Pipeline Products by Stage of Development
Pipeline Products - Monotherapy Get complete
TOC here _at_ http//www.bigmarketresearch.com/neuron
-biopharma-sa-product-pipeline-review-2014-market
8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/neuron-biopharma-
sa-product-pipeline-review-2014-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
sales_at_bigmarketresearch.com